The Committee on Ethical Conduct of the 36th Legislature has extended its investigation into Senator At-Large Angel Bolques Jr. until May 30, citing the need for a thorough and impartial review of serious allegations, including workplace harassment, financial mismanagement, and the creation of a hostile work environment.
The inquiry was initiated following a formal internal complaint filed on March 26. The committee, chaired by Senate Vice President Kenneth L. Gittens and comprising Sens. Dwayne M. DeGraff, Novelle E. Francis Jr., Carla J. Joseph and Kurt A. Vialet, was originally expected to deliver its advisory opinion by April 25, in accordance with legislative rules. However, preliminary interviews and evidence gathering indicated that additional time was necessary to ensure a comprehensive investigation.
In a statement released Tuesday, the committee emphasized its commitment to conducting the inquiry with integrity and impartiality, adhering strictly to legislative guidelines. No further public statements will be made until the conclusion of the investigation to preserve the integrity of the proceedings, according to the release.
Senate President Milton Potter, who appointed the committee, has recused himself from the investigation to maintain its independence. He previously stated that the Legislature has a responsibility to take every complaint seriously and follow a structured, impartial process, ensuring that all parties have the opportunity to be heard.
The Committee on Ethical Conduct has previously addressed similar matters, including the 2021 review of a complaint against Sen. Marvin Blyden for violating COVID-19 quarantine protocols and the 2022 investigation of sexual misconduct allegations against then-Sen. Steven Payne Sr., who was ultimately expelled from the Legislature. Bolques was appointed to fill the vacant Senator-At-Large seat following Payne’s removal.
The outcome of the current investigation will be submitted to the Senate President as an official advisory opinion once the review concludes. No timeline for public disclosure of findings has been announced.
